Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from Artrya Limited ( (AU:AYA) ).
Artrya Limited announced the issuance of 262,856 fully paid ordinary shares following the exercise of vested employee incentive restricted stock units. This move is in line with the company’s compliance with relevant sections of the Corporations Act, indicating a strategic step in rewarding employees while maintaining regulatory standards.
More about Artrya Limited
Artrya Limited is a Perth-based applied artificial intelligence healthcare company founded in 2018 and listed on the Australian Securities Exchange in 2021. It focuses on improving the diagnosis of coronary heart disease using its patented AI platform, which aids clinicians in predicting and preventing acute coronary events.
YTD Price Performance: 54.72%
Average Trading Volume: 160,537
Technical Sentiment Consensus Rating: Sell
Find detailed analytics on AYA stock on TipRanks’ Stock Analysis page.